Global reports on Glutamicibacter: a mini review

Glutamicibacter has been recently reclassified from the genus Arthrobacter and represents a rare group of actinobacteria with significant biotechnological potential. Based on 16S rRNA signatures and phylogenomic evidence, its species have been discovered in diverse habitats including soils, sediments, wetlands, permafrost, saline coasts, and deserts. Ecologically, they act as endophytes, rhizosphere partners, and pioneers in extreme environments, reflecting exceptional resilience. These rare actinobacteria exhibit distinct biochemical profiles and follow a rod-coccus life cycle dependent on growth phase. Genomic surveys reveal compact genomes containing biosynthetic gene clusters (BGCs) that encode novel metabolites. Functionally, Glutamicibacter produces cold-activated and thermoalkaliphilic enzymes, antioxidant exopolysaccharides, uric acid-degrading pathways, and antimicrobial compounds. They have applications in food safety, agriculture, bioremediation, and therapeutics. However, BGCs remain uncharacterized in most species, and mechanisms underlying plant-microbe and insect-microbe interactions are poorly understood. Additionally, the industrial development of their enzymes and metabolites is limited. This review integrates contemporary perspectives on the taxonomy, ecology, morphology, genomics, and metabolism of Glutamicibacter and identifies future prospects through genome mining, metabolomics, and synthetic biology.